Show simple item record

dc.contributor.authorSaliani, N
dc.contributor.authorMontazersaheb, S
dc.contributor.authorMontasser Kouhsari, S
dc.date.accessioned2018-08-26T04:54:21Z
dc.date.available2018-08-26T04:54:21Z
dc.date.issued2017
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/38126
dc.description.abstractMicroRNAs (miRNAs) are endogenous non-coding RNAs that have significant roles in biological processes such as glucose homoeostasis. MiRNAs fine-tune target genes expression via sequence-specific binding of their seed sequence to the untranslated region of mRNAs and degrade target mRNAs. MicroRNAs in islet ?-cells regulate ?-cell differentiation, proliferation, insulin transcription and glucose-stimulated insulin secretion. Furthermore, miRNAs play key roles in the regulation of glucose and lipid metabolisms and modify insulin sensitivity by controlling metabolic functions in main target organs of insulin such as skeletal muscle, liver and adipose tissue. Moreover, since circulating miRNAs are detectable and stable in serum, levels of certain miRNAs seem to be novel biomarkers for prediction of diabetes mellitus. In this article, due to the prominent impact of miRNAs on diabetes, we overviewed the microRNAs regulatory functions in organs related to insulin resistance and diabetes and shed light on their potential as diagnostic and therapeutic markers for diabetes.
dc.language.isoEnglish
dc.relation.ispartofAdvanced pharmaceutical bulletin
dc.titleMicromanaging Glucose Tolerance and Diabetes.
dc.typearticle
dc.citation.volume7
dc.citation.issue4
dc.citation.spage547
dc.citation.epage556
dc.citation.indexPubmed
dc.identifier.DOIhttps://doi.org/10.15171/apb.2017.066


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record